Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating stereotactic body radiation therapy for stage I non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) [Phase 2]
Phase 2 study evaluating temozolomide for brain metastases from melanoma, breast cancer, or non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing Genexol (paclitaxel) plus cisplatin versus Genexol-PM (paclitaxel-loaded micelle) plus cisplatin in advanced Non-Sma…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) [Phase 2]
Phase 2 trial of temozolomide for brain metastases from non-small cell lung cancer has completed; the study status is listed as COMPLETED.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib [Phase 2]
Phase 2 study of LDK378 (alectinib) in adults with ALK-activated non-small cell lung cancer who were previously treated with chemotherapy an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial testing Erlotinib and Cetuximab in patients with advanced solid tumors, with emphasis on …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK
A completed clinical trial evaluating neutropenic sepsis and related resource use in non-small cell lung cancer patients treated with single…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose pulsatile erlotinib or gefitinib in patients with advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy [Phase 2]
A Phase 2 study evaluating a high-dose icotinib regimen in patients with advanced non-small cell lung cancer after failure of prior targeted…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Hypermetabolism in the Elderly Lung Cancer Patient
A completed clinical trial examining hypermetabolism in elderly patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 3]
Phase 3 trial comparing high-dose or standard-dose radiation therapy with chemotherapy, with or without cetuximab, in newly diagnosed stage …
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Endobronchial Ultrasound vs Mediastinoscopy in NSCLC [Phase 2]
A Phase 2 trial comparing endobronchial ultrasound with mediastinoscopy for mediastinal evaluation in non-small cell lung cancer has complet…
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer [Phase 1]
A Phase I trial update reports completion of induction therapy with Velcade (bortezomib) and vorinostat in patients with surgically resectab…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)
An observational study evaluating erlotinib (Tarceva) in participants with locally advanced or metastatic non-small cell lung cancer (adenoc…
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy [Phase 2]
A completed Phase 2 study evaluated CT perfusion imaging to assess non-small cell lung cancer before and after chemotherapy with or without …
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer [NA]
The clinical trial evaluating losartan for pulmonary fibrosis in patients with stage I–III non-small cell lung cancer has been withdrawn.
-
FDA approval · 2017-05-01FDA Approved: IMFINZI — Original Application (AstraZeneca Pharmaceuticals LP)
The FDA approved the original application for Imfinzi (durvalumab) from AstraZeneca, marking its first approved indication.
-
FDA approval · 2017-04-28FDA Approved: ALUNBRIG — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approves ALUNBRIG (brigatinib) under the original NDA for ALK-positive non-small cell lung cancer.
-
FDA approval · 2017-04-28FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific [Phase 2]
Phase II single-arm trial of AZD9291 (osimertinib) for non-small cell lung cancer patients in the Asia-Pacific region has completed and resu…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating whether proteomic profiling can predict response to erlotinib in patients with stage IIIB/IV or recurrent no…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial evaluated safety and efficacy of carboplatin/paclitaxel with and without bevacizumab, and with or without pictilisib, in …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating imatinib mesylate combined with paclitaxel in older patients with stage IIIB or stage IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy [NA]
A completed clinical trial evaluating vitamin supplementation in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes
An update indicates that a clinical trial evaluating internet-based clinical information collection and blood sample collection from never-s…